1. People's Republic of China Stocks

  2. •

    Healthcare

  3. •

    Medical - Diagnostics & Research
Thalys Medical Technology Group Inc.

Thalys Medical Technology Group Inc.

603716.SS
Thalys Medical Technology Group Inc.CN flagShanghai Stock Exchange
14.78
CNY
-0.21
- -
3.34BMarket Cap

Total Valuation

Thalys Medical Technology Group Inc. carries a market capitalization of 3.34B, placing it among publicly traded companies globally. Its enterprise value stands at 3.64B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Market Cap3.34B
Enterprise Value3.64B

Share Statistics

Thalys Medical Technology Group Inc. currently has 191.02M shares outstanding.

Shares Outstanding191.02M
Owned by Insiders (%)N/A
Owned by Institutions (%)N/A

Valuation Ratios

The price-to-sales ratio is 2.08, and the price-to-book ratio stands at 16.37.

PE RatioN/A
PS Ratio2.08
PB Ratio16.37
P/TBV Ratio3.81
P/FCF Ratio135.03
P/OCF RatioN/A

Enterprise Valuation

EV / Sales2.57
EV / EBITDAN/A
EV / EBITN/A
EV / FCF44.64

Financial Position

Thalys Medical Technology Group Inc. maintains a current ratio of 1.73, meaning it holds 1.7x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 100.07, indicating elevated leverage, while an interest coverage ratio of -1.39 demonstrates limited ability to service its debt obligations.

Current Ratio1.73
Quick Ratio0.14
Debt / Equity100.07
Debt / EBITDA-12.17
Interest Coverage-1.39

Financial Efficiency

Return on Equity (ROE)-82.63
Return on Assets (ROA)-9.64
Return on Invested Capital (ROIC)N/A
Return on Capital Employed (ROCE)N/A
Revenue Per EmployeeN/A
Employee CountN/A
Inventory Turnover3.96

Taxes

Income Tax39.95M
Effective Tax RateN/A

Stock Price Statistics

Thalys Medical Technology Group Inc.'s stock has declined approximately -34.39858% over the past 52 weeks. The 50-day moving average sits at 18.14, while the 200-day moving average is 21.90.

Beta (5Y)N/A
52-Week Price Change-34.39858%
50-Day Moving Average18.14
200-Day Moving Average21.90
Average Volume (20 Days)N/A

Income Statement

Over the trailing twelve months, Thalys Medical Technology Group Inc. generated 1.42B in revenue and converted that into -260.59M in net income, yielding earnings per share of -1.24. EBITDA reached -69.78M, while operating income came in at -69.78M.

Revenue1.42B
Gross Profit276.37M
Operating Income-69.78M
Pretax Income-213.34M
Net Income-260.59M
EBITDA-69.78M
EBIT-69.78M
Earnings Per Share (EPS)-1.24

Balance Sheet

Thalys Medical Technology Group Inc. holds 123.22M in cash and equivalents against 849.09M in total debt, resulting in a net debt position of 668.73M. Total book value stands at 179.91M, with working capital of 624.07M providing operational flexibility.

Cash & Cash Equivalents123.22M
Total Debt849.09M
Net Debt668.73M
Equity (Book Value)179.91M
Book Value Per Share0.88
Working Capital624.07M

Cash Flow

After subtracting -21.82M in capital expenditures, free cash flow totaled -21.82M - equivalent to -0.11 per share.

Operating Cash FlowN/A
Capital Expenditures-21.82M
Free Cash Flow-21.82M
FCF Per Share-0.11

Margins

Thalys Medical Technology Group Inc. operates with a gross margin of 19.48, reflecting its pricing power and cost economics. The operating margin of -4.92 and net profit margin of -18.37 provide insight into operational efficiency.

Gross Margin19.48
Operating Margin-4.92
Pretax Margin-15.04
Profit Margin-18.37
EBITDA Margin-4.92

Dividends & Yields

The company's payout ratio of -6.06 indicates the proportion of earnings distributed to shareholders.

Dividend Per Share0.07
Dividend YieldN/A
Payout Ratio-6.06
Shareholder Yield6.12
FCF Yield0.74

Stock Splits

Thalys Medical Technology Group Inc.'s most recent stock split took place on April 25, 2018 with a 2:5 split ratio.

Last Split Date4/25/2018
Split Ratio2:5

Scores

Thalys Medical Technology Group Inc. posts an Altman Z-Score of 2.21, near the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.

Altman Z-Score2.21